Travere Therapeutics, Inc. (TVTX)
27.23
-0.06
(-0.22%)
USD |
NASDAQ |
Mar 06, 16:00
27.70
+0.47
(+1.73%)
After-Hours: 20:00
Travere Therapeutics Free Cash Flow : -20.37M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Revolution Medicines, Inc. | -913.73M |
| ICU Medical, Inc. | 82.83M |
| Tandem Diabetes Care, Inc. | -29.67M |
| iRhythm Holdings, Inc. | 34.52M |
| Eli Lilly & Co. | 5.964B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 60.68M |
| Cash from Investing (Quarterly) | -104.84M |
| Cash from Financing (Quarterly) | 26.68M |
| Free Cash Flow Per Share (Quarterly) | 0.4631 |
| Free Cash Flow to Equity (Quarterly) | 42.83M |
| Free Cash Flow to Firm (Quarterly) | 44.21M |
| Free Cash Flow Yield | -0.81% |